Fibril-forming proteins: The amyloidosis. New hopes for a disease that cardiologists must know;Proteine che "fibrillano": L'amiloidosi. Nuove speranze per una malattia che il cardiologo deve conoscere

Italian Heart Journal Supplement

Volumn 3, Issue 6, 2002, Pages 590-597

  Arbustini, Eloisa ^a   Gavazzi, Antonello ^a   Merlini, Giampaolo ^a  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Amyloid; Apolipoproteins; Restrictive cardiomyopathy

Indexed keywords

AMYLOID A PROTEIN; AMYLOID PROTEIN; APOLIPOPROTEIN A1; IMMUNOGLOBULIN LIGHT CHAIN; PREALBUMIN;

ASPIRATION BIOPSY; AUTOIMMUNE DISEASE; AUTOSOMAL DOMINANT DISORDER; AUTOTRANSPLANTATION; CELL CLONE; CHRONIC INFLAMMATION; CORRELATION ANALYSIS; DIAGNOSTIC APPROACH ROUTE; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAM; FAMILIAL MEDITERRANEAN FEVER; FAMILY HISTORY; GENE MUTATION; GENOTYPE; HEART AMYLOIDOSIS; HEART MUSCLE BIOPSY; HEART TRANSPLANTATION; HUMAN; PHENOTYPE; PLASMA CELL; PROTEIN ANALYSIS; PROTEIN CONFORMATION; PROTEIN SYNTHESIS; REVIEW; STEM CELL TRANSPLANTATION; URINALYSIS;

AMYLOIDOSIS; APOLIPOPROTEIN A-I; BIOPSY, NEEDLE; CARDIOMYOPATHIES; CARDIOMYOPATHY, RESTRICTIVE; HUMANS; IMMUNOPHENOTYPING; PREALBUMIN; SERUM AMYLOID A PROTEIN;

EID: 0036067507     PISSN: 11294728     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (42)

1. Cardiac amyloidosis causing cardiac dysfunction: Analysis of 54 necropsy patients
2. The systemic amyloidoses: An overview
3. The functional defect in amyloid heart disease. The "stiff heart" syndrome
4. Cardiac immunocyte-derived (AL) amyloidosis: An endomyocardial biopsy study in 11 patients
5. Symptomatic ischemic heart disease resulting from obstructive intramural coronary amyloidosis
6. Amyloidosis limited to small arteries causing angina pectoris and sudden death
7. Nomenclature of amyloid fibril proteins. Report from the meeting of the International Nomenclature Committee on Amyloidosis, August 8-9, 1998. Part 1
8. Infusion of light chains from patients with cardiac amyloidosis causes diastolic dysfunction in isolated mouse hearts
9. Amyloid P component. A critical review
10. Specificity of abnormal assembly in immunoglobulin light chain deposition disease and amyloidosis
11. A molecular model for self-assembly of amyloid fibrils from immunoglobulin light chains
12. Tertiary structure of an amyloid immunoglobulin light chain protein: A proposed model for amyloid fibril formation
13. Primary systemic amyloidosis: Clinical and laboratory features in 474 cases
14. Expression and hypermutation of human immunoglobulin kappa genes
15. Variable kappa gene rearrangement in lymphoproliferative disorders: An analysis of V kappa gene usage, VJ joining and somatic mutation
16. Benc-Jones proteins and light chains of immunoglobulins. Preferential association of the V lambda VI subgroup of human light chains with amyloidosis AL (lambda)
17. Amyloidosis
18. Hematopoietic cell transplantation for primary systemic amyloidosis: What have we learned
19. New drug therapy of amyloidoses: Resorption of AL-type deposits with 4′-iodo-4′-deoxydoxorubicin
20. Long term results of heart transplantation in patients with amyloid heart disease
21. Serum amyloid A (SAA): Biochemistry, genetics and the pathogenesis of AA amyloidosis
22. Transthyretin amyloidosis
23. Cardiac amyloid in patients with familial amyloid polyneuropathy consists of abundant wild-type transthyretin
24. Progressive cardiac amyloidosis following liver transplantation for familial amyloid polyneuropathy: Implications for amyloid fibrillogenesis
25. Progression of ventricular wall thickening after liver transplantation for familial amyloidosis
26. The new apolipoprotein A-I variant leu(174) → Ser causes hereditary cardiac amyloidosis, and the amyloid fibrils are constituted by the 93-residue N-terminal polypeptide
27. Dialysis-related amyloidosis of the heart in long-term hemodialysis patients
28. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement
29. Comprehensive Doppler assessment of right ventricular diastolic function in cardiac amyloidosis
30. Familial and primary (AL) cardiac amyloidosis: Echocardiographically similar diseases with distinctly different clinical outcomes
31. Sensitivity and specificity of the echocardiographic features of cardiac amyloidosis
32. Comparison of electrocardiographic findings in patients with AL (primary) amyloidosis and in familial amyloid polyneuropathy and anginal pain and their relation to histopathologic findings
33. Cardiac and pleuropulmonary AL amyloid imaging with technetium-99m labelled aprotinin
34. Light and electron microscopy immunohistochemical characterization of amyloid deposits. Amyloid
35. Endomyocardial biopsy-proven light chain amyloidosis (AL) without echocardiographic features of infiltrative cardiomyopathy
36. Contribution of magnetic resonance imaging in the differential diagnosis of cardiac amyloidosis and symmetric hypertrophic cardiomyopathy
37. Diagnostic screening of systemic amyloidosis by abdominal fat aspiration: An analysis of 100 cases
38. On the binding of Congo Red by Amyloid
39. Electron and immuno-electron microscopy of abdominal fat identify and characterize amyloid fibrils in suspected cardiac amyloidosis
40. Immunochemical microanalysis of amyloid proteins in fine-needle aspirates of abdominal fat
41. Amyloid cardiomyopathy: Diagnosis and treatment
42. Therapeutic advances demand accurate typing of amyloid deposits